CD79A and cancer: Apart from IgG, other isotypes IgE, IgA and IgM have also shown encouraging results for designing immunotherapeutic approaches in the area of cancer therapeutics (Josephs et al., 2014; Leusen, 2015; Kretschmer et al., 2017).